194 related articles for article (PubMed ID: 19176870)
1. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
Chakravarty G; Santillan AA; Galer C; Adams HP; El-Naggar AK; Jasser SA; Mohsin S; Mondal D; Clayman GL; Myers JN
Exp Biol Med (Maywood); 2009 Apr; 234(4):372-86. PubMed ID: 19176870
[TBL] [Abstract][Full Text] [Related]
2. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of mature insulin-like growth factor (IGF)-II leads to growth arrest in Caco-2 human colon cancer cells.
Kim EJ; Holthuizen PE; Kim J; Park JH
Growth Horm IGF Res; 2005 Feb; 15(1):64-71. PubMed ID: 15701574
[TBL] [Abstract][Full Text] [Related]
6. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
Elliott DD; Sherman SI; Busaidy NL; Williams MD; Santarpia L; Clayman GL; El-Naggar AK
Hum Pathol; 2008 Jan; 39(1):15-20. PubMed ID: 17949783
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
8. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
Fottner Ch; Hoeflich A; Wolf E; Weber MM
Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
[TBL] [Abstract][Full Text] [Related]
9. Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer.
An Y; Cai L; Wang Y; Zhu D; Guan Y; Zheng J
Onkologie; 2009 Nov; 32(11):638-44. PubMed ID: 19887867
[TBL] [Abstract][Full Text] [Related]
10. OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.
Ruangpratheep C; Lohachittranond C; Poonpracha T; Punyarit P
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S281-9. PubMed ID: 16858970
[TBL] [Abstract][Full Text] [Related]
11. [Expression of IGF-I and IGF-IR in bladder cancer].
Xie QX; Lin XC; Zhang MF; Han CX; Guo YH
Ai Zheng; 2004 Jun; 23(6):707-9. PubMed ID: 15191677
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor as a marker for prognosis and a therapeutic target in human esophageal squamous cell carcinoma.
Imsumran A; Adachi Y; Yamamoto H; Li R; Wang Y; Min Y; Piao W; Nosho K; Arimura Y; Shinomura Y; Hosokawa M; Lee CT; Carbone DP; Imai K
Carcinogenesis; 2007 May; 28(5):947-56. PubMed ID: 17183068
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study.
Basolo F; Pollina L; Pacini F; Fontanini G; Ménard S; Castronovo V; Bevilacqua G
Clin Cancer Res; 1996 Oct; 2(10):1777-80. PubMed ID: 9816129
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma.
Zhao R; Macdonald K; Casson AG
Mol Carcinog; 2009 Nov; 48(11):982-8. PubMed ID: 19582762
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive.
Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL
Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma.
Broecker-Preuss M; Sheu SY; Worm K; Feldkamp J; Witte J; Scherbaum WA; Mann K; Schmid KW; Schott M
Horm Metab Res; 2008 Oct; 40(10):685-91. PubMed ID: 18622894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]